# EUROAPI FRANCE, Vertolaye, France – FDA Inspections

Source: https://www.keypedia.com/companies/euroapi-france/2ee4d708-ba85-484a-a754-7c4b82673bb8

> Inspection records and compliance data for EUROAPI FRANCE in Vertolaye. 9 FDA inspections on record, last inspected March 08, 2024.

---

## Details

- Name: EUROAPI FRANCE
- FEI Number: 1463
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, PACK
- Address Line 1: 4 Lieu Dit La Paterie
- City: Vertolaye
- Country Name: France
- Address: 4 Lieu Dit La Paterie, Vertolaye, France
- Country: France

## Related Documents

- FDA Inspection 1260661 - EUROAPI FRANCE - 2024-03-08 — classification: No Action Indicated (NAI), source: FDA, date: March 8, 2024
- FDA Inspection 1260661 - EUROAPI FRANCE - 2024-03-08 — classification: No Action Indicated (NAI), source: FDA, date: March 8, 2024
- FDA Inspection 1248566 - EUROAPI FRANCE - 2022-02-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 11, 2022
- [FDA Inspection 1248566 - EUROAPI FRANCE - 2022-02-11](https://www.keypedia.com/records/fda_inspections/euroapi-france/c4959b32-4a6c-4017-a6d1-d52d7fd1d711) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 11, 2022
- [FDA Inspection 1129392 - EUROAPI FRANCE - 2020-02-27](https://www.keypedia.com/records/fda_inspections/euroapi-france/dcaa00fb-7f1d-426c-a8e5-66f4c9fdc102) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 27, 2020
- [FDA Inspection 1098786 - EUROAPI FRANCE - 2019-06-28](https://www.keypedia.com/records/fda_inspections/euroapi-france/749b209d-3195-4037-84a5-b6de318ddf1b) — classification: No Action Indicated (NAI), source: FDA, date: June 28, 2019
- FDA Inspection 1067732 - EUROAPI FRANCE - 2017-11-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 17, 2017
- [FDA Inspection 987999 - EUROAPI FRANCE - 2016-09-16](https://www.keypedia.com/records/fda_inspections/euroapi-france/94cef12c-c622-470a-9762-0fc0d7121060) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 16, 2016
- FDA Inspection 896712 - EUROAPI FRANCE - 2014-09-26 — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2014
- FDA Inspection 896712 - EUROAPI FRANCE - 2014-09-26 — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2014

## Related Companies

- [Aurisco Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/aurisco-pharmaceutical-co-ltd/0c1b2448-eac7-44af-8316-098b271b404f)
- [Kyowa Pharma Chemical Co Ltd](https://www.keypedia.com/companies/kyowa-pharma-chemical-co-ltd/abbdeec9-240e-41e0-a8fd-2d49162d244a)
- [FDC Limited (Roha Plant)](https://www.keypedia.com/companies/fdc-limited-roha-plant/b8a83576-62a0-439a-98c7-d18cee2c3f18)
- [Orchid Pharma Ltd.](https://www.keypedia.com/companies/orchid-pharma-ltd/8fcbbb91-e867-488a-9553-608edacb945d)
- [Alexion Pharma International Operations Unlimited Co.](https://www.keypedia.com/companies/alexion-pharma-international-operations-unlimited-co/8da873c2-2cc1-4ece-9643-0f90227f6f9f)
- [Excella GmbH & Co. KG](https://www.keypedia.com/companies/excella-gmbh-co-kg/82bb94ef-8b2e-4e51-8c40-b71a184257f1)
- [Changzhou Pharmaceutical Factory](https://www.keypedia.com/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4)
- [Boehringer Ingelheim Pharma GmbH & Co. KG](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263)
- [NorthStar Medical Radioisotopes, LLC](https://www.keypedia.com/companies/northstar-medical-radioisotopes-llc/2ae91764-ce9b-4c3f-949b-bce9a564ba89)
- [Granules India Limited](https://www.keypedia.com/companies/granules-india-limited/cdb2aa54-4375-4df2-8142-93321bdc2e2d)